Lux Health Tech Acquisition cancelled an Oct. 13 shareholder meeting to consider a six-month deadline extension and announced it will dissolve, instead, effective Oct. 29.
The SPAC last month said it had entered into a non-binding letter of intent for a business combination with an unnamed life sciences company addressing “significant unmet needs in some of the most costly and debilitating segments of healthcare.”
This month marks the two-year anniversary of Lux Health’s $345 million IPO. Read more.
